Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: The effects of ramipril, nifedipine and moxonidine

Journal of the American Society of Nephrology

Volumn 7, Issue 5, 1996, Pages 667-675

  Törnig, Johannes ^a   Amann, Kerstin ^a,b   Ritz, Eberhard ^a   Nichols, Cornelia ^a   Zeier, Martin ^a   Mall, Gerhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Department of Pathology ^*  (Germany)

Author keywords

ACE inhibitors; Calcium channel blockers; Short term renal failure; Sympathicolytic treatment

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MOXONIDINE; NIFEDIPINE; RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTERIOLE; ARTICLE; CAPILLARY DENSITY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; HEART DEATH; HEART MUSCLE CAPILLARY; INTERSTITIUM; KIDNEY FAILURE; MALE; MOUSE; NONHUMAN; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; STEREOMETRY; SYSTOLIC BLOOD PRESSURE;

EID: 0030357960     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Raine AEG, Margreiter R, Brunner FP, et al.: Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 1992;7(Suppl 2):7-35.
2. European Dialysis and Transplantation Association: Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant 1995;10(Suppl 5):12.
3. US Renal Data System. Causes of death. Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995;14:79-90.
4. Clyne N, Lins LE, Pehrsson S: Occurrence and significance of heart disease in uremia. Scand J Urol Nephrol 1986;20:307-311.
5. Strauer BE: The significance of coronary reserve in clinical heart disease J Am Coll Cardiol 1990;15:775-783.
6. Parfrey PS, Harnett JD: Clinical aspects of cardiomyopathy in dialysis patients. Blood Purif 1994;12:267-276
7. Amann K, Neusüß R, Ritz E, Irzyniec T, Wiest G, Mall G: Changes of vascular architecture independent of blood pressure in experimental uremia. Am J Hypertens 1995; 8:409-417.
8. Amann K, Wiest G, Zimmer G, Gretz N, Ritz E, Mall G: Reduced capillary density in the myocardium of uremic rats. A stereological study. Kidney Int 1992;42:1111-1117.
9. Mall G, Rambausek M, Neumeister A, Kollmar S, Vetterlein F, Ritz E: Myocardial interstitial fibrosis in experimental uremia, implications for cardiac compliance. Kidney Int 1988;33:804-811.
10. Amann K, Ritz E: Reduced cardiac ischemia tolerance in uremia - What is the role of structural abnormalities of the heart? Nephrol Dial Transplant, in press.
11. Cannella G, La Canna G, Sandrini M, et al.: Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients. Nephrol Dial Transplant 1991;6:31-37.
12. Silberberg J, Racine N, Barre P, Sniderman AD: Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can J Cardiol 1990;6:1-4.
13. Gwathmey JK, Copelas L, MacKinnon R, et al.: Abnormal intracellular calcium handling in myocardium from patients with end stage heart failure. Circ Res 1987;61: 70-76.
14. Ritz E, Koch M: Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 1993;21(Suppl 2):113-118.
15. Raine AE, Seymour AM, Roberts AF, Radda GK, Ledingham JG: Impairment of cardiac function and energetics in experimental renal failure. J Clin Invest 1993;92: 2934-2940.
16. Rostand SG, Kirk KA, Rutsky EA: Dialysis ischemic heart disease: Insights from coronary angiography. Kidney Int 1984;25:653-659.
17. Mattfeldt T, Mall G, Gharehbaghi H, Möller P: Estimation of surface area and length with the orientator. J Microsc (Oxf) 1990;159:301-317.
18. Weibel ER. Practical Methods for Biological Morphometry. Vol 1. Stereological Methods. London: Academic Press; 1979.
19. 2. Microvasc Res 1976;12:35-41.
20. Wiest G, Gharehbaghi H, Amann K, Simon T, Mattfeldt T, Mall G: Physiologic growth of arteries in the rat heart parallels the growth of capillaries, but not of myocytes. J Mol Cell Cardiol 1992;24:1423-1431.
21. Amann K, Greber D, Gharehbaghi H, et al.: Effects of Nifedipine and Moxonidine on cardiac structures in spontaneously hypertensive rats. Stereological studies on myocytes, capillaries, arteries and cardiac interstitium. Am J Hypertens 1992;5:76-83.
22. Bidani AK, Griffin KA, Picken M, Lansky DM: Continuous telemetric blood pressure monitoring and glomerular injury in the rat remnant kidney model. Am J Physiol 1993;265:F391-F398.
23. Rambausek M, Ritz E, Mall G, Mehls O, Katus H: Myocardial hypertrophy in rats with renal insufficiency. Kidney Int 1985;28:775-782.
24. Fliser D, Schweizer C, Ritz E: How many patients with renal insufficiency survive until end-stage renal failure? [Letter.] Nephrol Dial Transplant 1991;6:600.
25. Kakinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa I, Fogo A: Blood pressure independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 1992;42:46-55.
26. Mulvany MJ, Baandrup U, Gundersen HJG: Evidence for hyperplasia in mesenteric resistance vessels of SHR using a three dimensional dissector. Circ Res 1985;57: 794-800.
27. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ: Small arterial structure in hypertension. Dual process of remodeling and growth. Hypertension (Dallas) 1993;21:391-397.
28. Barenbrock M, Spieker C, Laske V, et al.: Study of vessel wall properties in hemodialysis patients. Kidney Int 1994;45:1397-1400.
29. Griffin KA, Bidani AK, Picken M, Ellis VR, Churchill PC: Prostaglandins do not mediate impaired autoregulation or increased renin secretion in remnant rat kidneys. Am J Physiol 1992;263:F1057-F1062.
30. Pugh CW, Ebert BL, Ebrahim O, Maxwell PH, Ratcliffe PJ: Analysis of cis-acting sequence required for operation of erythropoietin 3′ enhancer in different cell lines. Ann NY Acad Sci 1994;718:31-41.
31. Torry JR, Connel PM, O'Brien DM, Chilian WM, Tomanek RJ: Sympathectomy stimulates capillary but not precapillary growth in hypertrophic hearts. Am J Physiol 1991;260H:1515-1521.
32. Campese VM: Is hypertension in chronic renal failure neurogenic nature? Nephrol Dial Transplant 1994;7: 741-742.
33. Stella A, Zanchetti A: Functional role of renal afferents. Phys Rev 1991;71:659-677.
34. Suzuki H, Schaefer L, Ling H, et al.: Prevention of cardiac hypertrophy in experimental chronic renal failure by long-term ACE-inhibitor administration: Potential role of lysosomal proteinases. Am J Nephrol 1995; 15:129-136.
35. Amann K, Ritz E, Wiest G, Klaus G, Mall G: A role of parathyroid hormone for the activation of cardiac flbroblasts in uremia. J Am Soc Nephrol 1994;4:1814-1819.
36. Tan LB, Brilla C, Weber KT: Prevention of structural changes in the heart in hypertension. J Hypertens 1992; 10(Suppl):31-34.